跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Thapsigargin
首页
药物
Thapsigargin
Thapsigargin
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Reagents and methods for cancer treatment and prevention
US 9107863 B2
申请人: NIAZI KAYVAN R
优先权: 2006
CN
US
6 件公开
Remedy for cerebral neurodegenerative diseases using ppar agonist
US 2007037882 A1
申请人: ASTELLAS PHARMA INC
优先权: 2003
US
WO
2 件公开
Inhibitors of thapsigargin-induced cell death
US 2008293699 A1
申请人: BURNHAM INST MEDICAL RESEARCH
优先权: 2008
US
2 件公开
CRAC channel and modulator screening methods
US 2008039392 A1
申请人: UNIV CALIFORNIA
优先权: 2007
US
Folate-conjugated molecules for delivery of toxic small molecule inhibitors to cancer cells and methods of use
US 10525139 B2
申请人: DANA FARBER CANCER INST INC
优先权: 2015
US
Medicine composition for treating non-traumatic femoral head necrosis and preparation method thereof
CN 106539861 A
申请人: JI'NAN HAOYU QINGTIAN MEDICINE TECH CO LTD
优先权: 2016
CN
Synthesis of thapsigargin, nortrilobolide, and analogs thereof
US 11168064 B2
申请人: UNIV KINGSTON
优先权: 2018
US
Application of luteolin in preparation of drug for relieving endoplasmic reticulum stress of pancreatic beta cells
CN 110693870 A
申请人: UNIV SOUTHERN MEDICAL
优先权: 2018
CN
CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MODULATORS FOR TREATING AUTOSOMAL RESESSIVE POLYCYSTIC KIDNEY DISEASE
US 2022331301 A1
申请人: UNIV JOHNS HOPKINS
优先权: 2022
US
化合物Thapsigargin在制备预防或治疗猪流行性腹泻药物中的应用
CN 116098893 B
申请人: 中国农业科学院兰州兽医研究所
优先权: 2023
CN
药物
反馈